1H-Azepine → 4-[2-(2-Azepan-1-yl-ethyl)-benzofuran-5-yl]-benzonitrile
Reaction equation
CS(O[CH2:6][CH2:7][C:8]1[O:9][C:10]2[CH:16]=[CH:15][C:14]([C:17]3[CH:22]=[CH:21][C:20]([C:23]#[N:24])=[CH:19][CH:18]=3)=[CH:13][C:11]=2[CH:12]=1)(=O)=O.[NH:25]1[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=[CH:26]1>>[N:25]1([CH2:6][CH2:7][C:8]2[O:9][C:10]3[CH:16]=[CH:15][C:14]([C:17]4[CH:22]=[CH:21][C:20]([C:23]#[N:24])=[CH:19][CH:18]=4)=[CH:13][C:11]=3[CH:12]=2)[CH2:31][CH2:30][CH2:29][CH2:28][CH2:27][CH2:26]1Participants
3
Procedure
The product from Example 1C and azepine were processed as described in Example 1D to provide the titled compound. MS (DCI) m/z 345 (M+H)+;
Sources & evidence
- ORD record
- ord-896c9e82020d440389463903cb0f010a
- Source dataset
- uspto-grants-2005_11
- Patent number
- US06969730B2
Reaction notes
Loading…